Autopsy report · NCT06188637

Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study

“Funder decision”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Geert D'Haens

Sponsor type

University, hospital or other

Conditions

Ulcerative Colitis

Interventions

Ozanimod Oral Capsule

Participants

0

Trials that died the same way

• Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
  “due to a development decision by the funder” (70% match in meaning)
• Evaluating the CAREchart@Home™ Program for Enhancing After-hours Cancer Care
  “Due to unforeseen circumstances, the funder decided to discontinue all funding.” (58% match in meaning)
• MISP 60528 Pneumococcal Vaccination
  “Termination of funding by the sponsor/funder.” (57% match in meaning)
• Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
  “Business decision.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.